| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cryptochrome circadian regulator 2 | 0.599 | 0.692 | 3.2E-04 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator like | 0.510 | 0.885 | 0.99 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2011 | ||||||||
|
carbonic anhydrase 9 | 0.483 | 0.731 | 1.3E-09 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
period circadian regulator 3 | 0.559 | 0.731 | 1.4E-17 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.210 | None | 1.000 | 1 | 4 | 2010 | 2016 | ||||||||
|
cysteine and histidine rich domain containing 1 | 0.792 | 0.192 | 0.90 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
oxysterol binding protein 2 | 0.780 | 0.346 | 4.3E-04 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2001 | 2003 | ||||||||
|
microRNA 17 | 0.459 | 0.846 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2013 | |||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
cadherin 2 | 0.535 | 0.731 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
FRAT regulator of WNT signaling pathway 1 | 0.653 | 0.462 | 0.32 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
microRNA 1275 | 0.670 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 1301 | 0.711 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
Leukemia, acute lymphoblastic, susceptibility to, 2 | 0.861 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||
|
microRNA 2278 | 1.000 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
microRNA 3142 | 1.000 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
microRNA 4701 | 0.931 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
protein tyrosine phosphatase receptor type U | 0.581 | 0.654 | 0.39 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase domain 8 | 0.590 | 0.731 | 2.2E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
leucine rich pentatricopeptide repeat containing | 0.493 | 0.769 | 2.3E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
transducer of ERBB2, 1 | 0.674 | 0.462 | 0.95 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
Epstein-Barr virus induced 3 | 0.474 | 0.808 | 0.11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
abl interactor 2 | 0.700 | 0.423 | 0.43 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 |